Biology of neoplasia
A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
Breast Cancer
Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer
Chemotherapy Use for Hormone Receptor–Positive, Lymph Node–Negative Breast Cancer
Roles of Radiotherapy and Chemotherapy in the Development of Contralateral Breast Cancer
Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
Epidemiology
Body-Mass Index and Progression of Hepatitis B: A Population-Based Cohort Study in Men
Genitourinary Cancer
Clinical Outcome and Predictors of Survival in Late Relapse of Germ Cell Tumor
Gynecologic Cancer
RCAness" Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutation
Head and Neck Carcinomas
Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma
Neurooncology
Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
Phase I and Clinical Pharmacology
Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors
Review Articles
Nonpharmacologic Strategies for Managing Common Chemotherapy Adverse Effects: A Systematic Review
Sarcoma
Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma
Thoracic oncology
EGFR Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan
Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non–Small-Cell Lung Cancer
Treatment-Related Complications
Late Congestive Heart Failure After Hematopoietic Cell Transplantation
